terry_salyer

BioNano Genomics appoints chief commercial officer

pharmafile | March 27, 2015 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BioNano Genomics, Terry Salyer 

Genome mapping San Diego firm BioNano Genomics has appointed Terry Salyer as its chief commercial officer.

Salyer has more than 20 years of experience building sales teams in life sciences, and at BioNano will oversee the commercialisation of its genome-mapping platform.

Prior to joining the US company Salyer was the vice president of worldwide sales at ProteinSimple, and previous to this role was VP of worldwide sales at ForteBio – where she played a part in selling the business to Pall Corporation.

Advertisement

Salyer’s previous positions include vice president of worldwide sales and service at Eksigent Technologies and director of sales at Molecular Devices.

Erik Holmlin the president and chief executive of BioNano Genomics says: “We look forward to working with Terry, who will lead and build BioNano’s worldwide sales teams for significant growth and adoption of the Irys System.”

Salyer adds: “The BioNano team has created the only commercial genome mapping system, and I look forward to helping genomics researchers access the Irys System to obtain a comprehensive view of complex genomes.”

Related Content

No items found
The Gateway to Local Adoption Series

Latest content